Early Screening and Treatment of Heart Complication in Sickle Cell Disease
NCT: NCT07023666 · RECRUITING
NCT IDNCT07023666
StatusRECRUITING
Start Date2025-10-07
Completion2027-12-30
SponsorInova Health Care Services (OTHER)
First posted
Last updated
Brief Summary
This study tests whether early heart screening and treatment for iron overload in subjects with sickle cell disease can prevent heart problems and reduce hospitalizations.
Frequently Asked Questions
What is Early Screening and Treatment of Heart Complication in Sickle Cell Disease?
Early Screening and Treatment of Heart Complication in Sickle Cell Disease is a clinical trial registered under NCT07023666. Current status: RECRUITING.
What is the status of NCT07023666?
The current status of NCT07023666 (Early Screening and Treatment of Heart Complication in Sickle Cell Disease) is: RECRUITING.
When did Early Screening and Treatment of Heart Complication in Sickle Cell Disease start?
Early Screening and Treatment of Heart Complication in Sickle Cell Disease started on 2025-10-07.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.